Archive: 13/09/2018
Study details incidence and timing of immunotherapy-related fatalities
Vanderbilt-Ingram Cancer Center researchers have answered questions about the incidence and timing of rare but sometimes fatal reactions to the most widely prescribed class of immunotherapies.
Sep 13, 2018